0001311241-14-000157.txt : 20141230 0001311241-14-000157.hdr.sgml : 20141230 20141230161614 ACCESSION NUMBER: 0001311241-14-000157 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141230 ITEM INFORMATION: Other Events FILED AS OF DATE: 20141230 DATE AS OF CHANGE: 20141230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTERMOLECULAR INC CENTRAL INDEX KEY: 0001311241 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 201616267 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35348 FILM NUMBER: 141316248 BUSINESS ADDRESS: STREET 1: 3011 NORTH FIRST STREET CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: (408) 582-5700 MAIL ADDRESS: STREET 1: 3011 NORTH FIRST STREET CITY: SAN JOSE STATE: CA ZIP: 95134 8-K 1 a20148-kxmicron.htm 8-K 2014 8-K - Micron


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 8-K
 

CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): December 30, 2014
 
Intermolecular, Inc.
(Exact Name of Registrant as Specified in Charter)
 


 
 
 
Delaware
001-35348
20-1616267
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)



3011 N. First Street
San Jose, California
95134
(Address of Principal Executive Offices)
(Zip Code)



(408) 582-5700
(Registrant's Telephone Number, Including Area Code)



N/A
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




ITEM 8.01. OTHER EVENTS


On April 1, 2013, we entered into a collaborative development agreement with Micron Technology, Inc. (“Micron”) (the “Micron CDP”) to develop and improve certain advanced memory products.  The Micron CDP has two development programs, one in the field of DRAM and the other in the field of Non-Volatile Memory (“NVM”).  Micron recently informed the Company that it will not continue with the NVM portion of the Micron CDP effective April 1, 2015.  However, the Micron CDP remains in effect and the DRAM program remains active.  The terms of the ownership of the technology created under the NVM program and licenses under any intellectual property rights resulting from such technology remain unchanged, and any obligation of Micron to pay success fees for the NVM development program may continue after the end of the NVM program.

The foregoing description of the Micron CDP does not purport to be complete and is qualified in its entirety by reference to the agreement filed as an exhibit to our Form 10-Q filed with the Securities and Exchange Commission on August 7, 2013.

 

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
INTERMOLECULAR, INC.
 
 
 
 
Date: December 30, 2014
 
By:
/s/ Bruce M. McWilliams
 
 
 
Bruce M. McWilliams
 
 
 
President and Chief Executive Officer